Skip to main content

Table 1 Demographic and clinical parameters of patients on admission

From: Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer

Characteristic

OCT group ( n= 48)

Control group ( n= 48)

P

Age (mean ± S.D., year)

54.2 ± 7.3

53.2 ± 7.9

0.532

ECOG

  

0.604

3

10

8

4

38

40

Predominant sites of cancer (CT scanning)

  

0.871

Pleural

3

2

Peritoneal

15

19

Omental

3

4

Liver metastasis

7

5

More than one site

20

18

Predominant symptoms

  

0.677

Nausea and vomiting

46

44

Bloating

20

16

0.399

Constipation

16

19

0.525

Abdominal pain

35

29

0.194